Posted On: 09/17/2012 1:48:29 PM
Post# of 99138
Pacific Biosciences of California, Inc.
Nasdaq
2.09 0.06 (2.96%) at 13:29:00 EST
| Period Ending | Dec 31, 2011 | Dec 31, 2010 | ||
|---|---|---|---|---|
| Total Revenue | 33,863 | 1,674 | ||
| Cost of Revenue | 20,829 | - | ||
| Gross Profit | 13,034 | 1,674 | ||
Operating Expenses | ||||
| Research and Development | 76,080 | 111,821 | ||
| Sales, General and Admin. | 46,710 | 30,087 | ||
| Non-Recurring Items | - | - | ||
| Other | - | - | ||
| Operating Income | (109,756) | (140,234) | ||
Income From Continuing Operations | ||||
| Add'l Income/Expense Items | 368 | 68 | ||
| Earnings Before Interest and Tax | (109,388) | (140,166) | ||
| Interest Expense | - | - | ||
| Earnings Before Tax | (109,388) | (140,166) | ||
| Income Tax | - | - | ||
| Minority Interest | - | - | ||
| Equity Earnings Unconsolidated Subsidiary | - | - | ||
| Net Income Cont. Operations | (109,388) | (140,166) | ||
Non Recurring Events | ||||
| Discontinued Operations | - | - | ||
| Extraordinary Items | - | - | ||
| Effect of Accounting Changes | - | - | ||
| Other Items | - | - | ||
| Net Income | (109,388) | (140,166) | ||
| Preferred Stock and Other Adjustments | - | - | ||
| Net Income Applicable to Common Shareholders | (109,388) | (140,166) | ||
(0)
(0)
